BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
National Grid
NGG
$71B
| $3.4M | ﹤0.01% |
58,971
+31,979
| +118% | +$1.85M |
|
1327
Core Scientific
CORZ
$4.84B
| $3.39M | ﹤0.01% |
241,456
+88,872
| +58% | +$1.25M |
|
1328
Main Street Capital
MAIN
$5.99B
| $3.38M | ﹤0.01% |
57,773
+30,046
| +108% | +$1.76M |
|
1329
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.46B
| $3.37M | ﹤0.01% |
+36,000
| New | +$3.37M |
|
1330
Halozyme
HALO
$8.99B
| $3.36M | ﹤0.01% |
70,344
+28,849
| +70% | +$1.38M |
|
1331
iShares Short-Term National Muni Bond ETF
SUB
$10.3B
| $3.36M | ﹤0.01% |
31,852
+25,606
| +410% | +$2.7M |
|
1332
Sarepta Therapeutics
SRPT
$1.82B
| $3.34M | ﹤0.01% |
27,448
+117
| +0.4% | +$14.2K |
|
1333
Varonis Systems
VRNS
$6.3B
| $3.33M | ﹤0.01% |
74,938
-6,253
| -8% | -$278K |
|
1334
Olo Inc
OLO
| $3.32M | ﹤0.01% |
+432,241
| New | +$3.32M |
|
1335
Rush Enterprises Class A
RUSHA
$4.33B
| $3.31M | ﹤0.01% |
60,422
-8,596
| -12% | -$471K |
|
1336
Applied Industrial Technologies
AIT
$9.94B
| $3.31M | ﹤0.01% |
13,817
-6,961
| -34% | -$1.67M |
|
1337
OneMain Financial
OMF
$7.2B
| $3.31M | ﹤0.01% |
63,436
+15,437
| +32% | +$805K |
|
1338
Knight Transportation
KNX
$6.77B
| $3.3M | ﹤0.01% |
62,235
-68,559
| -52% | -$3.64M |
|
|
BBBY
1339
Bed Bath & Beyond, Inc.
BBBY
$596M
| $3.3M | ﹤0.01% |
668,415
+579,826
| +655% | +$2.86M |
|
1340
First Trust Energy AlphaDEX Fund
FXN
$281M
| $3.29M | ﹤0.01% |
201,265
-46,735
| -19% | -$764K |
|
1341
America's Car Mart
CRMT
$286M
| $3.27M | ﹤0.01% |
63,866
+25,368
| +66% | +$1.3M |
|
1342
Encompass Health
EHC
$12.7B
| $3.27M | ﹤0.01% |
35,387
-3,010
| -8% | -$278K |
|
1343
CRISPR Therapeutics
CRSP
$5.12B
| $3.27M | ﹤0.01% |
82,994
-4,962
| -6% | -$195K |
|
1344
AST SpaceMobile
ASTS
$10.4B
| $3.26M | ﹤0.01% |
+154,674
| New | +$3.26M |
|
1345
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.8B
| $3.26M | ﹤0.01% |
32,491
-144,740
| -82% | -$14.5M |
|
1346
Telus
TU
$24.3B
| $3.25M | ﹤0.01% |
239,792
+103,967
| +77% | +$1.41M |
|
|
MTTR
1347
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $3.24M | ﹤0.01% |
+683,631
| New | +$3.24M |
|
1348
iShares US Telecommunications ETF
IYZ
$607M
| $3.23M | ﹤0.01% |
120,558
+118,130
| +4,865% | +$3.17M |
|
1349
FS KKR Capital
FSK
$4.91B
| $3.21M | ﹤0.01% |
+147,722
| New | +$3.21M |
|
1350
Soleno Therapeutics
SLNO
$2.85B
| $3.21M | ﹤0.01% |
+71,320
| New | +$3.21M |
|